Health & Food
Experimental drug shows promise in treating Alzheimer's disease
BOSTON (KABC) -- An experimental drug shows promise in treating Alzheimer's disease, according to the combined results of two scientific studies.
The drug, called solanezumab, was the subject of two studies on Alzheimer's patients. Each study's results were insufficient to significantly slow the disease, but combining the two studies' results showed 34 percent less mental decline in mild Alzheimer's patients compared to a placebo treatment over 18 months.
The results are not expected to be strong enough to win approval for the drug for the time being. Doctors say though that the results indicate researchers are making progress on the right track toward treating Alzheimer's by clearing sticky deposits that clog patients' brains.
The results of the two studies were released at a Boston neurology conference Monday.
The drug is being developed by Eli Lilly and Company.
The Associated Press contributed to this report.
health, health care, health & food
- S. Korea ferry: Evacuation order delayed 24 min ago
- Monterey Park fire engine crash injures 15
- 'X-Men' director accused of sexual assault
- Arsonist sought in San Pedro Elks Lodge fire
- Female pedestrian struck, killed in Riverside 16 min ago
- Police: 2 South LA fires may be connected 37 min ago
- LAX Terminal 7 partially evacuated over threat 24 min ago
- 1 dead, 9 injured in Fontana accident on 10W
- Operation Crossover targets liquor thieves
- Solvang ordnance scare prompts evacuations
- abcnews: Conjoined twins see sunlight for 1st time
- Oscar Pistorius trial: Forensic expert faulted
- Jay-Z's Made in America festival announced
- OTRC: Will Arnett files for divorce from Poehler